Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (4) , 91-95
- https://doi.org/10.1016/0732-8893(92)90134-f
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- RoxithromycinDrugs, 1989
- Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibioticAntimicrobial Agents and Chemotherapy, 1987
- Roxithromycin: a pharmacokinetic review of a macrolideJournal of Antimicrobial Chemotherapy, 1987
- Comparative pharmacokinetics of macrolidesJournal of Antimicrobial Chemotherapy, 1987
- Amoxicillin-Potassium Clavulanate: A Novel β-Lactamase InhibitorDrug Intelligence & Clinical Pharmacy, 1985
- In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics of Amoxicillin: Dose Dependence After Intravenous, Oral, and Intramuscular AdministrationAntimicrobial Agents and Chemotherapy, 1977